{
  "trial_id": "NCT00610714",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, prior chemotherapy regimens, baseline tumor size, baseline CA-125 levels, baseline liver function tests, baseline renal function tests, baseline hemoglobin levels, baseline bone marrow reserve, time since last platinum-containing therapy, disease stage at diagnosis, presence of BRCA mutation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Body Surface Area (BSA)",
        "World Health Organization (WHO) Performance Status",
        "Primary Tumour Location (Number of Participants)",
        "Tumour Grade"
      ],
      "remaining_candidate_features": [
        "Age",
        "ECOG performance status",
        "prior chemotherapy regimens",
        "baseline tumor size",
        "baseline CA-125 levels",
        "baseline liver function tests",
        "baseline renal function tests",
        "baseline hemoglobin levels",
        "baseline bone marrow reserve",
        "time since last platinum-containing therapy",
        "disease stage at diagnosis",
        "presence of BRCA mutation"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, prior chemotherapy regimens, baseline tumor size, baseline CA-125 levels, baseline liver function tests, baseline renal function tests, baseline hemoglobin levels, baseline bone marrow reserve, time since last platinum-containing therapy, disease stage at diagnosis, presence of BRCA mutation."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Stage of Ovarian Cancer at Diagnosis, Time Since Last Platinum Therapy, Number of Prior Chemotherapy Regimens, Baseline CA-125 Levels, Performance Status, Hemoglobin Levels, Liver Function Tests, Renal Function Tests, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "World Health Organization (WHO) Performance Status",
          "Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Body Surface Area (BSA)",
        "Primary Tumour Location (Number of Participants)",
        "Tumour Grade"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Stage of Ovarian Cancer at Diagnosis",
        "Time Since Last Platinum Therapy",
        "Number of Prior Chemotherapy Regimens",
        "Baseline CA-125 Levels",
        "Hemoglobin Levels",
        "Liver Function Tests",
        "Renal Function Tests"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Stage of Ovarian Cancer at Diagnosis, Time Since Last Platinum Therapy, Number of Prior Chemotherapy Regimens, Baseline CA-125 Levels, Performance Status, Hemoglobin Levels, Liver Function Tests, Renal Function Tests"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (Customized), Region of Enrollment, ECOG Performance Status, Prior chemotherapy regimens, Time since last platinum-based therapy, CA-125 level, Histological subtype of ovarian cancer.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "Gender"
        ],
        [
          "World Health Organization (WHO) Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Primary Tumour Location (Number of Participants)",
          "Histological subtype of ovarian cancer"
        ],
        [
          "Tumour Grade",
          "CA-125 level"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "Body Surface Area (BSA)"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Prior chemotherapy regimens",
        "Time since last platinum-based therapy"
      ]
    },
    "processed-gen-response": "Age, Gender, Region of Enrollment, ECOG Performance Status, Prior chemotherapy regimens, Time since last platinum-based therapy, CA-125 level, Histological subtype of ovarian cancer."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, time since diagnosis, time since last treatment, number of prior chemotherapy regimens, platinum-free interval, cancer antigen 125 (CA-125) levels, hemoglobin levels, platelet count, white blood cell count, creatinine levels, bilirubin levels, albumin levels, presence of ascites, presence of bowel obstruction.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Body Surface Area (BSA)",
          "body mass index (BMI)"
        ],
        [
          "World Health Organization (WHO) Performance Status",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ],
        [
          "number of prior chemotherapy regimens",
          "number of prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Primary Tumour Location (Number of Participants)",
        "Tumour Grade"
      ],
      "remaining_candidate_features": [
        "Age",
        "ethnicity",
        "time since diagnosis",
        "time since last treatment",
        "platinum-free interval",
        "cancer antigen 125 (CA-125) levels",
        "hemoglobin levels",
        "platelet count",
        "white blood cell count",
        "creatinine levels",
        "bilirubin levels",
        "albumin levels",
        "presence of ascites",
        "presence of bowel obstruction"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, time since diagnosis, time since last treatment, number of prior chemotherapy regimens, platinum-free interval, cancer antigen 125 (CA-125) levels, hemoglobin levels, platelet count, white blood cell count, creatinine levels, bilirubin levels, albumin levels, presence of ascites, presence of bowel obstruction."
  }
}